EdgeRock Capital LLC decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 4.3% during the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,252 shares of the healthcare conglomerate’s stock after selling 56 shares during the quarter. UnitedHealth Group accounts for about 0.3% of EdgeRock Capital LLC’s investment portfolio, making the stock its 28th biggest position. EdgeRock Capital LLC’s holdings in UnitedHealth Group were worth $602,000 at the end of the most recent quarter.
A number of other hedge funds have also recently modified their holdings of UNH. New Hampshire Trust boosted its holdings in shares of UnitedHealth Group by 0.8% in the second quarter. New Hampshire Trust now owns 7,925 shares of the healthcare conglomerate’s stock valued at $3,809,000 after purchasing an additional 59 shares during the period. Town & Country Bank & Trust CO dba First Bankers Trust CO boosted its holdings in shares of UnitedHealth Group by 3.4% in the second quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO now owns 6,300 shares of the healthcare conglomerate’s stock valued at $3,028,000 after purchasing an additional 206 shares during the period. Capital Investment Services of America Inc. boosted its holdings in shares of UnitedHealth Group by 26.6% in the second quarter. Capital Investment Services of America Inc. now owns 770 shares of the healthcare conglomerate’s stock valued at $370,000 after purchasing an additional 162 shares during the period. Baker Boyer National Bank boosted its holdings in shares of UnitedHealth Group by 4.7% in the second quarter. Baker Boyer National Bank now owns 1,170 shares of the healthcare conglomerate’s stock valued at $562,000 after purchasing an additional 53 shares during the period. Finally, Capital Investment Advisors LLC lifted its holdings in UnitedHealth Group by 1.7% during the second quarter. Capital Investment Advisors LLC now owns 15,495 shares of the healthcare conglomerate’s stock worth $7,447,000 after buying an additional 265 shares during the period. Institutional investors own 85.69% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research firms have weighed in on UNH. JPMorgan Chase & Co. upped their target price on UnitedHealth Group from $527.00 to $532.00 and gave the stock an “overweight” rating in a report on Monday, July 17th. SVB Securities lowered their target price on UnitedHealth Group from $625.00 to $560.00 in a report on Wednesday, June 14th. Morgan Stanley restated an “overweight” rating and set a $587.00 target price on shares of UnitedHealth Group in a report on Friday, July 14th. TD Cowen reduced their price target on UnitedHealth Group from $562.00 to $555.00 and set an “outperform” rating on the stock in a research report on Monday, July 17th. Finally, Royal Bank of Canada reduced their price target on UnitedHealth Group from $592.00 to $572.00 and set an “outperform” rating on the stock in a research report on Monday, July 17th. Two research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $575.65.
Insider Transactions at UnitedHealth Group
In other news, CEO Andrew Witty sold 4,000 shares of the stock in a transaction dated Wednesday, July 19th. The shares were sold at an average price of $506.19, for a total transaction of $2,024,760.00. Following the sale, the chief executive officer now directly owns 78,573 shares of the company’s stock, valued at approximately $39,772,866.87. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.35% of the company’s stock.
UnitedHealth Group Price Performance
Shares of UNH opened at $486.06 on Tuesday. The business’s 50-day moving average is $492.05 and its two-hundred day moving average is $486.73. The company has a market capitalization of $450.24 billion, a P/E ratio of 21.75, a P/E/G ratio of 1.43 and a beta of 0.66. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.80 and a current ratio of 0.80. UnitedHealth Group Incorporated has a fifty-two week low of $445.68 and a fifty-two week high of $558.10.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings results on Friday, July 14th. The healthcare conglomerate reported $6.14 earnings per share for the quarter, topping the consensus estimate of $5.92 by $0.22. UnitedHealth Group had a return on equity of 26.72% and a net margin of 6.06%. The company had revenue of $92.90 billion for the quarter, compared to the consensus estimate of $90.97 billion. During the same period last year, the firm earned $5.57 EPS. The firm’s revenue for the quarter was up 15.6% compared to the same quarter last year. Research analysts predict that UnitedHealth Group Incorporated will post 24.83 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 19th. Stockholders of record on Monday, September 11th will be paid a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a dividend yield of 1.55%. The ex-dividend date is Friday, September 8th. UnitedHealth Group’s payout ratio is currently 33.65%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
- Five stocks we like better than UnitedHealth Group
- How to Invest in the Entertainment Industry
- 2 Recession-Proof Intelligence Stocks to Defend Your Portfolio
- What is the NASDAQ Stock Exchange?
- 5 Reasons Mullen Automotive is About to Turn a Corner
- How to Start Investing in Real Estate
- Qualcomm and Apple Forge Ahead with New Modem Partnership
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.